Aurora Cannabis (ACB) Profit After Tax (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Profit After Tax of -$27.6 million for Q1 2026, down 127.29% year-on-year from $101.0 million in Q1 2025, and down 536.38% on a QoQ basis from $6.3 million in Q4 2025.
Aurora Cannabis (ACB) Profit After Tax (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Profit After Tax for 10 consecutive years, with -$27.6 million the latest figure, recorded in Q1 2026.
- Quarterly Profit After Tax fell 127.29% year-over-year to -$27.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$73.9 million (down 738.51% YoY) and the FY2026 annual result came in at -$42.4 million, down 256.81% from the prior year.
- Profit After Tax retreated to -$27.6 million in Q1 2026 per ACB's latest filing, from $6.3 million in the prior quarter.
- Over the last five years, Profit After Tax for ACB reached as high as $20.1 million in Q4 2024 and fell as low as -$4.7 billion in Q2 2023.
- A 5-year average of -$445.9 million and a median of -$17.1 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax slumped 5346.9% — and 2024, when it soared 260.6%.
- Year by year, Profit After Tax stood at -$530.2 million in 2022, then surged by 97.64% to -$12.5 million in 2023, then surged by 260.6% to $20.1 million in 2024, then plunged by 68.61% to $6.3 million in 2025, then slumped by 536.38% to -$27.6 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$27.6 million, $6.3 million, and -$38.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | -27.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.57 Mn |
| Dec 31, 2025 | 6.32 Mn |
| Sep 30, 2025 | -38.63 Mn |
| Jun 30, 2025 | -13.99 Mn |
| Mar 31, 2025 | -12.13 Mn |
| Dec 31, 2024 | 20.12 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | -20.27 Mn |
| Dec 31, 2023 | -12.53 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -4.71 Bn |
| Dec 31, 2022 | -530.22 Mn |
| Sep 30, 2022 | -514.23 Mn |
| Jun 30, 2022 | -483.95 Mn |
| Mar 31, 2022 | -799.09 Mn |
| Dec 31, 2021 | -59.61 Mn |
| Sep 30, 2021 | -9.44 Mn |
| Jun 30, 2021 | -108.99 Mn |
| Mar 31, 2021 | -130.09 Mn |